Preexposure prophylaxis for the prevention of HIV infection in the United States – 2017 Update clinical providers’ supplement

Details

• Corporate Authors:
  United States. Public Health Service. ; Centers for Disease Control and Prevention (U.S.) ; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of HIV/AIDS Prevention. Preexposure Prophylaxis Work Group.
• Description:
  The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 Clinical Providers’ Supplement was published in an electronic format in July 2014 so that it could be updated as relevant changes in supporting evidence became available. The Preexposure Prophylaxis for the Prevention of HIV Infection in the United States -2016 Update – Clinical Providers’ Supplement includes revisions to several sections. These revisions are highlighted throughout the document and are intended solely to update the developing evidence base and to clarify specific points in clinical care. No changes were made to the graded recommendations for the use of PrEP in the US.
  
  Suggested Citation: Centers for Disease Control and Prevention: US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: clinical providers’ supplement. https://www.cdc.gov/hiv/pdf/risk/prep-cdc-hiv-prep-provider-supplement-2017.pdf. Published March 2018.
  
  
• Content Notes:
  Introduction -- Section 1. Patient/Provider Checklist -- Section 2. Patient Information Sheet – PrEP -- Section 3. Patient Information Sheet – Truvada -- Section 4. Patient Information Sheet – Acute HIV Infection and PrEP -- Section 5. Provider Information Sheet – PrEP During Conception, Pregnancy, and Breastfeeding -- Section 6. HIV Incidence Risk Index for Men Who Have Sex With Men -- Section 7. HIV Incidence Risk Index for Persons Who Inject Drugs -- Section 8. Management of Patients Who Acquire HIV While on PrEP -- Section 9. Transition of Patients from nPEP to PrEP -- Section 10. Supplemental Counseling Information—Medication Adherence -- Section 11. Supplemental Counseling Information—HIV Risk Reduction -- Section 12. PrEP-related ICD, CPT and LOINC Codes -- Section 13. Potential PrEP Practice Quality Measures -- Section 14. Methods for Developing the PrEP Clinical Practice Guideline.
  
  Priya Jakhmola (CPY5@cdc.gov)
  
  4/20/2018
  
  
• Document Type:
  Text
• Genre:
  Practice Guideline
• Pages in Document:
  59 numbered pages
• Collection(s):
  Guidelines and Recommendations
• Main Document Checksum:
  urn:sha-512:698689c6d181067bdcff113462336d4e009472af0bcc8cc7854c4cd86ca9728070910688099e8f5a9b0f1f8bbaabba1fe39b3d1b1765e7a88bad26ac256e2cf0
• Download URL:
  https://stacks.cdc.gov/view/cdc/53508/cdc_53508_DS1.pdf
• File Type:
  [PDF - 1.62 MB ]